Filter
722
Text search:
quality
assured
medical
products
Featured
Recommendations
86
New Publications
238
Language
Document type
No document type
384
Guidelines
120
Studies & Reports
112
Manuals
48
Strategic & Response Plan
43
Training Material
10
Situation Updates
2
Fact sheets
2
Resource Platforms
1
Countries / Regions
India
38
Global
30
Kenya
23
Nigeria
19
Western and Central Europe
19
Uganda
17
Ethiopia
13
Zambia
13
Ghana
12
Tanzania
11
Myanmar / Burma
11
Nepal
10
Liberia
9
Philippines
9
South–East Asia Region
9
Bangladesh
8
Eastern Europe
8
Malawi
7
Lesotho
7
Africa
7
Sierra Leone
6
Cambodia
6
South Africa
6
Latin America and the Carribbean
6
Ukraine
5
West and Central Africa
5
Asia
5
Burkina Faso
4
Zimbabwe
4
Rwanda
4
Namibia
4
East and Southern Africa
4
Senegal
3
Congo, Democratic Republic of
3
Pakistan
3
Middle East and North Africa
3
Guinea
2
South Sudan
2
Iraq
2
Afghanistan
2
Germany
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Sri Lanka
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Laos
2
Georgia
2
USA
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Jordan
1
Syria
1
Thailand
1
Benin
1
Central African Republic
1
Brazil
1
Switzerland
1
Botswana
1
Libya
1
Guatemala
1
Bhutan
1
Tajikistan
1
Estonia
1
Iran
1
North America
1
Gabon
1
Maldives
1
United Kingdom
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
252
Clinical Guidelines
93
Public Health
47
Pharmacy & Technologies
35
Women & Child Health
29
Key Resources
21
Capacity Building
11
Toolboxes
TB
87
AMR
78
HIV
64
Pharmacy
51
COVID-19
36
NTDs
25
Rapid Response
21
Mental Health
17
Caregiver
12
Ebola
10
Polio
10
Conflict
10
Refugee
10
Global Health Education
10
Disability
9
NCDs
9
Natural Hazards
6
Planetary Health
6
Zika
5
Health Financing Toolbox
3
Specific Hazards
2
Cholera
1
Social Ethics
1
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional considerations in the procurement of rapid tests.
3rd Edition – July 2017
www.msfaccess.org
Towards the Peoples Health Assembly Book -5
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who release
...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a
...
Different situations, risks, recommendations. Short brochure with pictograms. Available in: English, Turkish, French, Russian at: http://www.bzga.de/infomaterialien/fremdsprachige-materialien/ AND German at: http://www.bzga.de/infomaterialien/aidsaufklärung/hiv-übertragung-und-aids-gefahr/
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
A survey of prevention, testing and treatment policies and practices
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
In the framework of the United Nations Sustainable Development Goals Issue-based Coalition on Health and Well-being for All at All Ages in Europe and Central Asia
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.
This action plan for the Kingdom Saudi Arabia to combat antimicrobial resistance has been formulated in the line of the WHO five objectives. It addresses the need for effective “one health” approach involving coordination among numerous national sectors and actors, including human and veterinary
...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
